Apr. 1 at 3:57 PM
$TRIB
To cut to the chase, this is either a complete zero… or one of the easiest 10x setups sitting in plain sight.
No in between.
Everyone knows:
• Dilution has been brutal
• Management hasn’t delivered
That’s exactly why it’s still a ~
$10M market cap
But RIGHT NOW:
• CGM heading to 2026 pivotal trial
• Company says it meets industry accuracy standards
• India/China market still in play
• Bayer LOI already happened
So let’s be real:
If this is truly dead → it goes to zero
If the tech works even halfway → this is NOT a
$10M company
Even with dilution, you don’t need much:
• one partner
• one real validation
• one rollout signal
👉 That’s how you get to
$5–
$10+
At
$0.60, the market is already calling it a failure.
I’m not convinced it is.
So which is it — zero… or massively mispriced? 👀
